source
- Biotech executive Steven Quay dropped from consideration for NIAID director roleSteven Quay, a biotech executive known for promoting the lab‑leak theory, was reportedly in the running to lead the National Institute for Allergy and Infectious Diseases. A source familiar with t…
- Life Biosciences injects experimental cellular reprogramming drug into three glaucoma patients, reports no serious adverse eventsLife Biosciences provided an update on its early‑stage glaucoma study involving its experimental cellular reprogramming therapy. The company said three patients have each received a single intravi…